+
Site Tour

EACTS 2021: A valve-for-life: when a myth becomes reality

Lorenzo Menicanti discusses with the panel and presents on "Mitral Valve Replacement in the current Era: New Guidelines and Considerations to Tailor the Treatment to Every Patient," at EACTS 2021.

Related Videos

Transcatheter Mitral Valve implant

TAVI Summit - Live case from Berlin

Now you've got Navitor.
Future ready.

AV VALVES 2023: The Genesis of TEER

PCRLV 2021: Transcatheter mitral valve replacement

Now you've got Navitor. Remarkable performance.

Review the Trends | Mitral focus

AV VALVES 2023:Decision Making in HF–Tricuspid

TRENDING TOPICS

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Early outcomes on Epic Max platfrom

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

Webinar PFO closure in patients >60 Years

Webinar PFO closure with Amplatzer™ Talisman™ PFO Occluder in patients >60 years

CONNEXT


HUB
RELATED RESOURCES

EuroEcho 2021: MR Treatment (Evidence)

PCRLV 2021: Transcatheter mitral valve replacement

Tendyne™: 6-Year Outcomes

TCT 21: EXPAND G4

CONNEXT


LIVE
RELATED EVENTS

AV Valves Summit 2024 | Opening of Day 2

Now you've got Navitor.
Future ready.

TAVI Summit - Cardiac imaging and morphology

Trending Controversies | AV Valves

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline